Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1986 | 12-1985 | 12-1984 | 12-1983 | 12-1982 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 558,200 | N/A | N/A | N/A | N/A |
| Depreciation Amortization | 177,700 | N/A | N/A | N/A | N/A |
| Other Operating Activity | 35,800 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $771,700 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 9,800 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 126,400 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $136,200 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 128,300 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $128,300 | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 397,900 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 1,146,000 | N/A | N/A | N/A | N/A |
| End Cash Position | 79,900 | N/A | N/A | N/A | N/A |
| Net Cash Flow | $3,900 | $N/A | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 771,700 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 771,700 | 0 | 0 | 0 | 0 |